What is the current term for diarrhea that responds to microbiota-targeted therapies?

What is the current term for diarrhea that responds to microbiota-targeted therapies?

• A. Microbiota-responsive diarrhea
• B. Antibiotic-responsive diarrhea (ARD)
• C. Diet-responsive diarrhea
• D. Steroid-responsive diarrhea

Answer: (A)

The main idea here is naming diarrhea by how it responds to therapies that specifically target the gut microbiota. When the diarrhea improves because we use interventions designed to shape or balance the microbial community—such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, or dietary strategies that significantly alter microbiota composition—the term microbiota-responsive diarrhea best captures that mechanism. It signals that the treatment effect comes from modifying the microbiome itself, not merely from killing pathogens or dampening inflammation. This is more accurate than antibiotic-responsive diarrhea, which implies benefit from antimicrobial drugs and focuses on the drug’s antimicrobial action rather than deliberate microbiota modulation. Steroid-responsive diarrhea points to immune-mediated disease that responds to immunosuppression, a different therapeutic pathway. Diet-responsive diarrhea can involve microbiota changes but doesn’t inherently denote targeted microbiota therapies, whereas microbiota-responsive diarrhea specifically aligns with interventions aimed at the microbial community.

The main idea here is naming diarrhea by how it responds to therapies that specifically target the gut microbiota. When the diarrhea improves because we use interventions designed to shape or balance the microbial community—such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, or dietary strategies that significantly alter microbiota composition—the term microbiota-responsive diarrhea best captures that mechanism. It signals that the treatment effect comes from modifying the microbiome itself, not merely from killing pathogens or dampening inflammation.

This is more accurate than antibiotic-responsive diarrhea, which implies benefit from antimicrobial drugs and focuses on the drug’s antimicrobial action rather than deliberate microbiota modulation. Steroid-responsive diarrhea points to immune-mediated disease that responds to immunosuppression, a different therapeutic pathway. Diet-responsive diarrhea can involve microbiota changes but doesn’t inherently denote targeted microbiota therapies, whereas microbiota-responsive diarrhea specifically aligns with interventions aimed at the microbial community.